These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 34553778)

  • 1. Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.
    Jakaria M; Belaidi AA; Bush AI; Ayton S
    J Neurochem; 2021 Dec; 159(5):804-825. PubMed ID: 34553778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis: A new strategy for targeting Alzheimer's disease.
    Qiang RR; Xiang Y; Zhang L; Bai XY; Zhang D; Li YJ; Yang YL; Liu XL
    Neurochem Int; 2024 Sep; 178():105773. PubMed ID: 38789042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
    Viktorinova A; Durfinova M
    Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease.
    Gleason A; Bush AI
    Neurotherapeutics; 2021 Jan; 18(1):252-264. PubMed ID: 33111259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration.
    Masaldan S; Bush AI; Devos D; Rolland AS; Moreau C
    Free Radic Biol Med; 2019 Mar; 133():221-233. PubMed ID: 30266679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of spermidine and ciprofloxacin against Alzheimer's disease in male rat via ferroptosis modulation.
    Youssef MAM; Mohamed TM; Bakry AA; El-Keiy MM
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130387. PubMed ID: 38401586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of liquid-liquid phase separation and ferroptosis in Alzheimer's disease.
    Wang F; Chen Z; Zhou Q; Sun Q; Zheng N; Chen Z; Lin J; Li B; Li L
    Neuropharmacology; 2024 Nov; 259():110083. PubMed ID: 39043267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.
    Derry PJ; Hegde ML; Jackson GR; Kayed R; Tour JM; Tsai AL; Kent TA
    Prog Neurobiol; 2020 Jan; 184():101716. PubMed ID: 31604111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
    Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
    Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review.
    Zhao D; Yang K; Guo H; Zeng J; Wang S; Xu H; Ge A; Zeng L; Chen S; Ge J
    Biomed Pharmacother; 2023 Aug; 164():114312. PubMed ID: 37210894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Role of Ferroptosis in Alzheimer's Disease.
    Zhang G; Zhang Y; Shen Y; Wang Y; Zhao M; Sun L
    J Alzheimers Dis; 2021; 80(3):907-925. PubMed ID: 33646161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis in Friedreich's Ataxia: A Metal-Induced Neurodegenerative Disease.
    La Rosa P; Petrillo S; Fiorenza MT; Bertini ES; Piemonte F
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33202971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage.
    Wan J; Ren H; Wang J
    Stroke Vasc Neurol; 2019 Jul; 4(2):93-95. PubMed ID: 31338218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
    Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
    Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta peptide, 4-hydroxynonenal and apoptosis.
    Lovell MA; Markesbery WR
    Curr Alzheimer Res; 2006 Sep; 3(4):359-64. PubMed ID: 17017866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.
    Ficiarà E; Munir Z; Boschi S; Caligiuri ME; Guiot C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant therapies for Alzheimer's disease.
    Feng Y; Wang X
    Oxid Med Cell Longev; 2012; 2012():472932. PubMed ID: 22888398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future Perspectives of Oxytosis/Ferroptosis Research in Neurodegeneration Diseases.
    Viktorinova A
    Cell Mol Neurobiol; 2023 Aug; 43(6):2761-2768. PubMed ID: 37093436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis: a potential therapeutic target for Alzheimer's disease.
    Yang L; Nao J
    Rev Neurosci; 2023 Jul; 34(5):573-598. PubMed ID: 36514247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The key roles of organelles and ferroptosis in Alzheimer's disease.
    Long HZ; Cheng Y; Zhou ZW; Luo HY; Wen DD; Gao LC
    J Neurosci Res; 2022 Jun; 100(6):1257-1280. PubMed ID: 35293012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.